Clinical Trial Update: Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab in combination with gemcitabine and cisplatin as preoperative neoadjuvant therapy for resectable intrahepatic cholangiocarc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Intrahepatic Cholangiocarcinoma (Icc) | Phase 2 | Status: RECRUITING